SCHEMBL2155137

SCHEMBL2155137

CC(C)(C)OC(=O)C1NC(C(=O)O)CC1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
CYP2D6 P10635 2/20 0.33
LMNA P02545 2/20 0.33
BLM P54132 2/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
BTK Q06187 1/20 0.33
GAA P10253 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31
NFKB1 P19838 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2155877 0.82 MAPK1 (0.33) MAPK1CYP2D6LMNABLMALOX15
SCHEMBL19520662 0.79 MAPK1 (0.41) MAPK1THRBGAANFKB1NFKB2
SCHEMBL3570843 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL2218168 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL29599645 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL1325536 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL2216604 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL8120909 0.75 MAPT (0.43) MAPK1LMNATSHRMEN1KMT2A
SCHEMBL9356138 0.73 CYP2D6 (0.56) MAPK1CYP2D6LMNABLMALOX15
SCHEMBL9356321 0.73 CYP2D6 (0.56) MAPK1CYP2D6LMNABLMALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861581-A1 IAP ANTAGONISTS Bristol-Myers Squibb Company (US) 2015-04-22 EP disclosed
WO-2013192286-A1 IAP ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-12-27 WO disclosed
WO-2013052369-A1 NOVEL BENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. (US) 2013-04-11 WO disclosed
EP-2512480-A1 HEPATITIS C VIRUS INHIBITORS Enanta Pharmaceuticals, Inc. (US) 2012-10-24 EP disclosed
WO-2011081918-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-07-07 WO disclosed